Premium
Donor‐derived regulatory dendritic cell infusion results in host cell cross‐dressing and T cell subset changes in prospective living donor liver transplant recipients
Author(s) -
Macedo Camila,
Tran Lillian M.,
Zahorchak Alan F.,
Dai Helong,
Gu Xinyan,
Ravichandran Ranjithkumar,
Mohanakumar Thalachallour,
Elinoff Beth,
Zeevi Adriana,
Styn Mindi A.,
Humar Abhinav,
Lakkis Fadi G.,
Metes Diana M.,
Thomson Angus W.
Publication year - 2021
Publication title -
american journal of transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.89
H-Index - 188
eISSN - 1600-6143
pISSN - 1600-6135
DOI - 10.1111/ajt.16393
Subject(s) - foxp3 , medicine , cd86 , immunology , cd8 , dendritic cell , interleukin 7 receptor , t cell , transplantation , cytotoxic t cell , immune system , il 2 receptor , biology , in vitro , biochemistry
Regulatory dendritic cells (DCreg) promote transplant tolerance following their adoptive transfer in experimental animals. We investigated the feasibility, safety, fate, and impact on host T cells of donor monocyte‐derived DCreg infused into prospective, living donor liver transplant patients, 7 days before transplantation. The DCreg expressed a tolerogenic gene transcriptional profile, high cell surface programed death ligand‐1 (PD‐L1):CD86 ratios, high IL‐10/no IL‐12 productivity and poor ability to stimulate allogeneic T cell proliferation. Target DCreg doses (range 2.5–10 × 10 6 cells/kg) were achieved in all but 1 of 15 recipients, with no infusion reactions. Following DCreg infusion, transiently elevated levels of donor HLA and immunoregulatory PD‐L1, CD39, and CD73 were detected in circulating small extracellular vesicles. At the same time, flow and advanced image stream analysis revealed intact DCreg and “cross‐dressing” of host DCs in blood and lymph nodes. PD‐L1 co‐localization with donor HLA was observed at higher levels than with recipient HLA. Between DCreg infusion and transplantation, T‐bet hi Eomes hi memory CD8 + T cells decreased, whereas regulatory (CD25 hi CD127 − Foxp3 + ): T‐bet hi Eomes hi CD8 + T cell ratios increased. Thus, donor‐derived DCreg infusion may induce systemic changes in host antigen‐presenting cells and T cells potentially conducive to modulated anti‐donor immune reactivity at the time of transplant.